citalopram has been researched along with Kidney Failure, Chronic in 6 studies
Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the effect of citalopram treatment on quality of life (QoL) and depression in 141 patients with chronic renal failure (CRF), QoL was measured by means of the Short Form 36 (SF-36)." | 3.74 | Antidepressant treatment increases quality of life in patients with chronic renal failure. ( Dervisoglu, E; Kalender, B; Ozdemir, AC; Yalug, I, 2007) |
| "There were no significant differences between the two groups in any of the pharmacokinetic parameters with the exception of the renal clearance of citalopram, which was significantly lower in the renal failure group than in the control group (1." | 2.69 | Citalopram pharmacokinetics in patients with chronic renal failure and the effect of haemodialysis. ( Dahlqvist, R; Hägg, S; Spigset, O; Stegmayr, B, 2000) |
| "Guidelines suggest treatment of depression in dialysis patients with pharmacological therapy, preferably a selective serotonin reuptake inhibitor." | 2.53 | Antidepressants for treating depression in adults with end-stage kidney disease treated with dialysis. ( Craig, JC; Natale, P; Palmer, SC; Rabindranath, KS; Ruospo, M; Saglimbene, VM; Strippoli, GF, 2016) |
| "Nonsudden cardiac death was treated as a competing event." | 1.51 | Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis. ( Assimon, MM; Brookhart, MA; Flythe, JE, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Assimon, MM | 1 |
| Brookhart, MA | 1 |
| Flythe, JE | 1 |
| Palmer, SC | 1 |
| Natale, P | 1 |
| Ruospo, M | 1 |
| Saglimbene, VM | 1 |
| Rabindranath, KS | 1 |
| Craig, JC | 1 |
| Strippoli, GF | 1 |
| Shin, YK | 1 |
| Hong, SC | 1 |
| Ihn, YK | 1 |
| Jeong, JH | 1 |
| Han, JH | 1 |
| Lee, SP | 1 |
| Hosseini, SH | 1 |
| Espahbodi, F | 1 |
| Mirzadeh Goudarzi, SM | 1 |
| Kalender, B | 1 |
| Ozdemir, AC | 1 |
| Yalug, I | 1 |
| Dervisoglu, E | 1 |
| Spigset, O | 1 |
| Hägg, S | 1 |
| Stegmayr, B | 1 |
| Dahlqvist, R | 1 |
1 review available for citalopram and Kidney Failure, Chronic
| Article | Year |
|---|---|
Antidepressants for treating depression in adults with end-stage kidney disease treated with dialysis.
Topics: Adult; Antidepressive Agents; Citalopram; Depression; Fluoxetine; Humans; Kidney Failure, Chronic; P | 2016 |
2 trials available for citalopram and Kidney Failure, Chronic
| Article | Year |
|---|---|
Citalopram versus psychological training for depression and anxiety symptoms in hemodialysis patients.
Topics: Antidepressive Agents, Second-Generation; Anxiety Disorders; Citalopram; Depressive Disorder; Female | 2012 |
Citalopram pharmacokinetics in patients with chronic renal failure and the effect of haemodialysis.
Topics: Adult; Aged; Antidepressive Agents; Area Under Curve; Biotransformation; Citalopram; Dealkylation; F | 2000 |
3 other studies available for citalopram and Kidney Failure, Chronic
| Article | Year |
|---|---|
Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis.
Topics: Age Factors; Aged; Aged, 80 and over; Cardiac Conduction System Disease; Citalopram; Death, Sudden, | 2019 |
A case of a patient with both chorea and restless legs syndrome.
Topics: Adult; Analgesics, Opioid; Anti-Dyskinesia Agents; Chorea; Citalopram; Drug Therapy, Combination; Ha | 2008 |
Antidepressant treatment increases quality of life in patients with chronic renal failure.
Topics: Adult; Aged; Antidepressive Agents; Citalopram; Depression; Female; Humans; Kidney Failure, Chronic; | 2007 |